|
Real-time Estimate
Cboe BZX
18:59:56 25/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 25.04 USD | +3.47% |
|
+3.00% | +51.67% |
| 02:57pm | B. Riley Adjusts Denali Therapeutics Price Target to $35 From $30, Maintains Buy Rating | MT |
| 08-24 | FDA places clinical hold on Regenxbio's gene therapy for Hunter Syndrome | RE |
Chart: Technical Analysis
Stock exchange
Nasdaq
DNLI 25.02 $
+3.39%
6.32M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| DNLI | 25.02USD | +3.39% | 6.32M $ | |
CBOE
| DNLI | 25.14USD | +3.88% | 259K $ | |
|
Boerse Muenchen
| 4DN | 21.45EUR | +3.22% | 8.58K € | |
|
Tradegate
| 4DN | 20.68EUR | -0.39% | 41.36 € | |
|
Deutsche Boerse AG
| 4DN | 20.61EUR | -2.04% | 0 € | |
|
Börse Stuttgart
| 4DN | 21.54EUR | +3.51% | 0 € | |
Sao Paulo
| D2NL34 | 27.06BRL | -1.31% | 54.12 R$ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bullish | Bullish |
| Resistance | 25.69 | 27.21 | 25.83 |
| Spread/Res. | -2.53% | -7.98% | -3.06% |
| Spread/Supp. | +10.55% | +14.18% | +36.83% |
| Support | 22.65 | 21.93 | 18.3 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DNLI Stock
- Charts Denali Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
